RGT 1.92% 26.5¢ argent biopharma limited

MXC Pros and Cons, page-3

  1. 4,303 Posts.
    lightbulb Created with Sketch. 482
    Not sure about the background of the Board however I do agree in a way that the harvest in Q4 is more likely for cosmetic to ensure they meet production target for their first order. It is not a bad thing though. Quick revenue to fund other operations.

    Isreal government provided funding recently to research on the methods for better cultivate Cannabis to extract good quality CBD oil. CBD oil market is quite immature and will not be ready at least min 12 months time.

    In regards to government regulations, I think it is in favour for MXC and other cannabis companies as many states in the US are legalising cannabis. Canada will be fully legalise cannabis in 2017.
    NSW, Vic, Queensland support medical cannabis. NSW Government funded 21M for research and other company fund their own research partnership with different universities.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.005(1.92%)
Mkt cap ! $12.82M
Open High Low Value Volume
26.0¢ 26.5¢ 26.0¢ $46 174

Buyers (Bids)

No. Vol. Price($)
2 9236 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 12 1
View Market Depth
Last trade - 14.23pm 09/08/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.